Carisma Therapeutics

Corporate

About

Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy. Our technology leverages advances in macrophage biology, chimeric antigen receptor engineering and adoptive cellular therapy for the treatment of human disease.

Membership Type

Corporate

Contacts

Primary
Tom Wilton
Chief Business Officer

Powered By GrowthZone